Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
BioPharma
Coley Pharmaceutical Group Regeneron Pharmaceuticals Checkmate Pharmaceuticals Art Krieg Zola Therapeutics Translate Bio
Source: biopharmadive.com